Affiliation:
1. Hospital Santa Marcelina, Brasil; Myogenética, Clínica de Doenças Neuromusculares, Brasil
2. Hospital Santa Marcelina, Brasil
Abstract
Lipid-lowering drugs have been occasionally associated with neuromuscular symptoms and muscle biopsy changes. We reported the clinical course and the muscle biopsy in eight patients with hyperlipoproteinemia, treated with lipid -lowering drugs (statins/fibrates). Five patients had myalgias while; in two cases there was proximal muscle weakness. All patients became asymptomatic after the withdrawal of the drug, although creatine kinase remained elevated. We performed muscle biopsy in six cases from three months to two years after suspension of the drug. We found variation in fibers diameters in all cases, with necrosis of fibers in five cases, inflammatory infiltration in one case, the presence of vacuolated fiber in one patient and ragged-red fibers in three subjects. We concluded that although the muscle biopsy findings were not specific, the prolonged use of statins and or fibrates might induce a chronic myopathy even in the absence of symptoms.
Subject
Neurology,Clinical Neurology
Reference18 articles.
1. Miopatías tóxicas en relacíon con la administración de hipolipidemiantes: son los fármacos los únicos responsables?;Galiana J;Rev Clin Esp,1995
2. Statin-associated myopathy;Hamilton-Craig I;Med J Aust,2001
3. Lipid-lowering drugs and mitochondrial function: effects of HMG Co A reductase inhibitors on serum ubiquinone and blood lactate/ pyruvate ratio;Pinieux G;Bri J Clin Pharmacol,1996
4. Statin-associated myopathy;Thompson PD;JAMA,2003
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献